Krohn KA - Search Results

1

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA. Schwartz JL, et al. Among authors: krohn ka. J Nucl Med. 2003 Dec;44(12):2027-32. J Nucl Med. 2003. PMID: 14660729 Free article.

2

18F-Fluorothymidine radiation dosimetry in human PET imaging studies.

Vesselle H, Grierson J, Peterson LM, Muzi M, Mankoff DA, Krohn KA. Vesselle H, et al. Among authors: krohn ka. J Nucl Med. 2003 Sep;44(9):1482-8. J Nucl Med. 2003. PMID: 12960196 Free article. Clinical Trial.

3

Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake.

Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA. Schwartz JL, et al. Among authors: krohn ka. Nucl Med Biol. 2004 May;31(4):419-23. doi: 10.1016/j.nucmedbio.2004.01.002. Nucl Med Biol. 2004. PMID: 15093811

4

Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography.

Grierson JR, Schwartz JL, Muzi M, Jordan R, Krohn KA. Grierson JR, et al. Among authors: krohn ka. Nucl Med Biol. 2004 Oct;31(7):829-37. doi: 10.1016/j.nucmedbio.2004.06.004. Nucl Med Biol. 2004. PMID: 15464384

5

Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.

Muzi M, Vesselle H, Grierson JR, Mankoff DA, Schmidt RA, Peterson L, Wells JM, Krohn KA. Muzi M, et al. Among authors: krohn ka. J Nucl Med. 2005 Feb;46(2):274-82. J Nucl Med. 2005. PMID: 15695787 Free article. Clinical Trial.

6

Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.

Muzi M, Mankoff DA, Grierson JR, Wells JM, Vesselle H, Krohn KA. Muzi M, et al. Among authors: krohn ka. J Nucl Med. 2005 Feb;46(2):371-80. J Nucl Med. 2005. PMID: 15695799 Free article.

7

Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.

Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B, Gibson DF, Krohn KA. Yagle KJ, et al. Among authors: krohn ka. J Nucl Med. 2005 Apr;46(4):658-66. J Nucl Med. 2005. PMID: 15809489 Free article.

8

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.

Muzi M, Spence AM, O'Sullivan F, Mankoff DA, Wells JM, Grierson JR, Link JM, Krohn KA. Muzi M, et al. Among authors: krohn ka. J Nucl Med. 2006 Oct;47(10):1612-21. J Nucl Med. 2006. PMID: 17015896 Free article.

9

Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.

Plotnik DA, Emerick LE, Krohn KA, Unadkat JD, Schwartz JL. Plotnik DA, et al. Among authors: krohn ka. J Nucl Med. 2010 Sep;51(9):1464-71. doi: 10.2967/jnumed.110.076794. Epub 2010 Aug 18. J Nucl Med. 2010. PMID: 20720049 Free PMC article.

10

The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells.

Plotnik DA, McLaughlin LJ, Krohn KA, Schwartz JL. Plotnik DA, et al. Among authors: krohn ka. Nucl Med Biol. 2012 Oct;39(7):970-6. doi: 10.1016/j.nucmedbio.2012.03.009. Epub 2012 May 5. Nucl Med Biol. 2012. PMID: 22560972 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters